AstraZeneca plans to increase investment and scale of its Virginia manufacturing facility to $4,5 billion and create 3,600 new jobs. Read more.
Bavarian Nordic announces that the consortium consisting of Nordic Capital and Permira has received final regulatory approval for its takeover offer to shareholders. Read more.
Coloplast announces that interim CEO lars rasmussen will leave the board at the upcoming annual general meeting. Read more.
Demant announces that the Chairman of the Board Niels B. Christiansen will not run for re-election. Read more.
Intellego Technologies appoints Henrik Resmark to new COO. Read more.
IRLAB Therapeutics appoints Gustaf Albert to new Chief Financial Officer. Read more.
Nexstim has received an order for NBS 6 systems from an American customer. Read more. Nexstim announces that their NBS 6 diagnostic system has received MDR certification in the EU. Read more.
Novo Nordisk acquires Akero Therapeutics and its promising Phase III FGF21 analog to expand its MASH portfolio. Read more.
Observe Medical announces that the last day of the subscription period in the subsequent offering has fallen. Read more.
OncoZenge reports that the first patient has been enrolled in the UCLA Patient Engagement Study. Read more.
Ortivus announces that all conditions for the issued underwriting in the ongoing rights issue have now been met. Read more.
PolarCool has extended its partnership with HC Davos for another two years. Read more.
Invitations & presentations
Immunovia Paxman Sedana Medical Vitrolife
Summons
Nomination committees
The latest from BioStock
» Novo Nordisk acquires Akero Therapeutics for USD 4,7 billion
» New nanotechnology shows promise in Alzheimer's disease
» Watch Diamyd Medical's live broadcast at BioStock
» Order book grows for SenzaGen
» Lead Biologics publishes groundbreaking study in Nature Cancer